Article

Preop and postop imaging vital for phakic IOLs

Preop and postop imaging and endothelial cell counts are vital to check the position and performance of a phakic IOLs, Dr David Hardten told colleagues.

Preop and postop imaging and endothelial cell counts are vital to check the position and performance of a phakic IOLs, Dr David Hardten told colleagues.

"Why do I use phakic IOLs? Well, it is a very good technique to correct very large errors while retaining accommodation, in both myopia as well as hyperopia," he said.

In general, as was shown in the FDA clinical trial, he said, the results with just minimal imaging, spectral microscopy and central anterior chamber depth, were actually quite good in respect of safety and the effects of the implant, both in clinical trials where phakic IOLs were iris fixated as well anterior chamber implants.

But complications do occur, and imaging can help to minimise the risk of them happening, "Phakic IOLs require the usual refractive work-up including refraction and others," said Dr Hardten. "But you also need the anterior chamber depth, and you should look for it at both the periphery as well as the centre."

Dr Hardten showed the audience how ultrasound with the A-Scan, optics with the Orbscan (Bausch & Lomb) or Pentacam (Oculus), or OCT could provide that information. Other key metrics are the angle-to-angle and sulcus-to-sulcus measurements. Surgeons can use ultrasound, optical or OCT to obtain these figures.

Dr Hardten noted that postoperative imaging was very important too. "Analyse clearance between IOL and endothelium, and between the IOL and the crystalline lens. You also need to check the IOL position in relation to the ciliary sulcus and finally, you must continue with your cell counts."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.